US Executive Compensation Proxy SEC Filings — July 09, 2026

09-07-2026

Firefly Neuroscience, Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders to be held virtually on August 5, 2026. The meeting includes six proposals: electing Arun Menawat as Class III director, ratifying CBIZ Canada as auditor, advisory vote on executive compensation, approving an amendment to the 2024 Long-Term Incentive Plan to increase shares by 2,000,000, approving a charter amendment to decrease authorized shares from 5,001,000,000 to 101,000,000, and approving adjournment if needed. The Board recommends voting 'For' all proposals.

• · Annual Meeting will be held virtually on August 5, 2026 at 10 a.m. Eastern Time.
• · Record date for voting is June 8, 2026.
• · Proposal 5 seeks to reduce authorized shares from 5,001,000,000 to 101,000,000 (100M common + 1M preferred).
• · Proposal 4 seeks to increase the Plan Share Limit by 2,000,000 shares.
• · The proxy statement is available at www.proxyvote.com and www.virtualshareholdermeeting.com/AIFF2026.

09-07-2026

TuHURA Biosciences, Inc. filed its definitive proxy statement (DEF 14A) for the 2025 fiscal year, detailing executive compensation, board composition, and corporate governance. Total compensation for CEO James Bianco decreased 34% YoY to $3,987,095, while CFO Dan Dearborn's total compensation fell 37% YoY to $1,832,036, primarily due to lower option awards. The board met 9 times in 2025, but the Nominating and Corporate Governance Committee held no meetings, and the Compensation Committee met only once.

• · The reverse merger with Kintara Therapeutics was completed on October 18, 2024, and management was replaced with Legacy TuHURA management.
• · All Section 16(a) filings were timely except for late Form 4s filed by Dan Dearborn and James A. Bianco for stock option grants on December 12, 2025, and by Craig Tendler for a grant on March 10, 2025.
• · The Board of Directors has no standing risk management committee; risk oversight is handled by the full board and its standing committees.
• · All then-current board members attended 75% or more of board and committee meetings in 2025.
• · The Audit Committee consists of James Manuso, Ph.D., Alan List, M.D., and George Ng.

09-07-2026

Leggett & Platt has agreed to be acquired by Somnigroup International Inc. in a stock-for-stock merger. Each share of Leggett & Platt common stock will be converted into 0.1455 shares of Somnigroup common stock. The merger requires approval by Leggett & Platt shareholders at a special meeting on August 20, 2026, and is unanimously recommended by the board of directors.

• · The exchange ratio is fixed at 0.1455 shares of Somnigroup common stock per Leggett & Platt share.
• · Merger sub (Sparrow Unity Corporation) was incorporated on April 9, 2026 specifically for this transaction.
• · The special meeting will be held virtually on August 20, 2026 at 10:00 a.m. Central Time.
• · Votes required: two-thirds for merger proposal; majority for advisory compensation proposal and adjournment proposal.

09-07-2026

EBR Systems, Inc. filed a definitive proxy statement (DEF 14A) for a Special Meeting of Stockholders to be held on August 18/19, 2026. The meeting seeks stockholder approval for two key proposals: (1) ratification of the issuance of 77,352,890 CDIs (equivalent to 7,735,289 shares) at A$0.38 per CDI under ASX Listing Rule 7.4, and (2) approval of the issuance of 92,105,270 CDIs (equivalent to 9,210,527 shares) at A$0.38 per CDI to clients of BCP3 Pty Ltd, an associate of director Dr. Chris Nave, under ASX Listing Rule 10.11. A third proposal seeks to adjourn the meeting if necessary to solicit additional proxies. The record date is July 7, 2026, and the company has 75,330,559 shares outstanding (equivalent to 753,305,590 CDIs).

• · Special Meeting will be held virtually via webcast at meetnow.global/MPMGPJK.
• · Record date for determining stockholders entitled to vote is July 7, 2026, at 7:00 pm AEST.
• · CDI holders cannot vote at the meeting; they must submit voting instructions by August 12, 2026, at 5:00 pm AEST.
• · Voting exclusions apply under ASX Listing Rule 14.11.1 for Proposals 1 and 2.
• · The company has 75,330,559 shares of common stock outstanding as of the record date.

09-07-2026

LivePerson Inc. is being acquired by SoundHound AI Inc. in a two-step merger. Stockholders will receive shares of SoundHound common stock (subject to a collar of $7.00-$12.00 per share) or cash for TASE shares, with an implied value of approximately $3.33 per LivePerson share, representing a 22% premium over the 30-day VWAP. The LivePerson board unanimously recommends approval, and a special meeting is scheduled for August 20, 2026.

• · The Per Share Merger Consideration is subject to a collar: SoundHound Closing Stock Price is floored at $7.00 and capped at $12.00 per share.
• · The Closing TASE Cash Merger Consideration is capped at $7.5 million.
• · The Aggregate Consideration Amount may be adjusted downward based on LivePerson's cash balance or upward based on option exercise prices.
• · LivePerson stockholders cannot transfer shares to TASE to become TASE Shares.
• · The special meeting will also vote on a non-binding compensation advisory proposal and an adjournment proposal, neither of which is a condition to the merger.
• · Failure to vote will have the same effect as a vote AGAINST the merger proposal.

09-07-2026

RE/MAX Holdings, Inc. (RMAX) is merging with Real (a Canadian company) to form New Wildlife, with RMAX stockholders receiving a fixed exchange ratio of 5.150 Real shares per RMAX share, subject to proration ensuring aggregate cash consideration between $60M and $80M. The merger is expected to close in the second half of 2026, but faces risks including stockholder approval, regulatory approvals, and potential termination by January 26, 2027. While the implied value of the stock election consideration was $13.80 per RMAX share on announcement day (April 24, 2026), it had declined to $11.33 by July 6, 2026, reflecting market volatility and uncertainty.

• · The merger agreement may be terminated if not completed by January 26, 2027, with automatic extensions to March 12, 2027 and April 26, 2027 if only regulatory conditions remain unsatisfied.
• · RMAX stockholders are entitled to severance payments and benefits on covered terminations, including those triggered by changes in duties or compensation post-merger.
• · Both Real and RMAX are restricted from making certain acquisitions, incurring debt, paying dividends above thresholds, or issuing securities outside existing equity award programs until closing.
• · The merger requires approval from both RMAX stockholders and Real securityholders, as well as court orders and regulatory approvals.
• · Key personnel may depart due to uncertainty about roles in New Wildlife, and retention planning is in place but not guaranteed.

09-07-2026

InnSuites Hospitality Trust (IHT) filed a DEF 14A proxy statement for its Fiscal 2026 Annual Meeting of Shareholders to be held on August 12, 2026. The meeting will cover the election of Trustee Steven S. Robson (Proposal 1) and ratification of BCRG Group as independent auditor (Proposal 2). As of the record date July 7, 2026, there were 9,402,834 shares outstanding. The Board recommends voting FOR both proposals.

• · The Board has five members divided into three classes; two trustees' terms expire in 2027, two in 2028, and one (if elected) in 2029.
• · Messrs. Marchi, Kutasi, and Robson are independent under NYSE American standards; Messrs. Berg and Wirth are not independent.
• · All trustees attended 100% of Board and committee meetings in Fiscal 2026.
• · BCRG Group audited the Trust for Fiscal 2025 and 2026; prior auditor BF Borgers audited from 2022 to 2024.
• · Shareholders may revoke a proxy by later proxy, written notice to the Secretary, or voting in person at the meeting.

09-07-2026

Ascend Wellness Holdings, Inc. filed a definitive proxy statement (DEF 14A) on July 9, 2026, for a special meeting of stockholders to be held virtually on August 28, 2026. The primary proposal is to approve a reverse stock split of Class A common shares at a ratio between 1-for-10 and 1-for-50, as determined by the Board, to facilitate a potential listing on a national securities exchange. A secondary proposal seeks approval to adjourn the meeting if necessary to solicit additional proxies.

• · Record date for the meeting is July 7, 2026.
• · Meeting password is 'ascend2026' (case-sensitive).
• · Proxies must be received by August 26, 2026 at 11:00 a.m. ET.
• · The reverse stock split is intended to help the company meet listing requirements for a national securities exchange.
• · The Board has discretion to choose the final split ratio within the 1-for-10 to 1-for-50 range.
• · The company is a Canadian reporting issuer and uses notice-and-access provisions for mailing materials.

09-07-2026

RYTHM, Inc. filed a definitive proxy statement (DEF 14A) for a virtual special meeting of stockholders to be held on August 10, 2026. The sole proposal is to approve the issuance of common stock to holders of convertible promissory notes and warrants and under shared services agreements, as required by Nasdaq Listing Rule 5635. As of the record date of June 26, 2026, the company had 2,179,128 shares outstanding and 52 holders of record.

• · The special meeting will be held virtually at www.virtualshareholdermeeting.com/RYM2026SM.
• · Stockholders of record as of June 26, 2026 are entitled to vote.
• · The board recommends voting FOR the issuance proposal.
• · A majority of votes cast is required for approval; abstentions have no effect.
• · The company had 52 holders of record as of the record date.

09-07-2026

New York Life Investments Funds Trust filed a definitive proxy statement (DEF 14A) for a special meeting of shareholders of the NYLI Epoch International Choice Fund to be held on September 28, 2026. Shareholders will vote on two proposals: (1) approving a new subadvisory agreement with Candriam to replace Epoch Investment Partners, which would trigger a fund repositioning including a name change to 'NYLIM Candriam International Core Equity Fund', modified investment strategies, a management fee reduction, and a new expense cap for Class I shares; and (2) authorizing the fund to operate under an expanded manager-of-managers structure allowing New York Life Investment Management to enter into or materially amend subadvisory agreements without future shareholder approval. The Board recommends voting FOR both proposals.

• · The special meeting will be held on September 28, 2026 at 10:00 a.m. Eastern time at 51 Madison Avenue, New York, NY.
• · Record date for voting is June 30, 2026.
• · Proxy materials will be first distributed on or about July 20, 2026.
• · If Proposal 1 is approved, changes will take effect on or about October 2, 2026.
• · The management fee will be reduced and a new expense cap for Class I shares will be adopted as part of the repositioning.
• · The fund will adopt a non-fundamental investment policy under Rule 35d-1 (Names Rule) of the 1940 Act.
• · Proposal 2 would allow the fund to disclose fees to New York Life Investment Management and wholly-owned subadvisors on an aggregate basis.